Recursion Pharmaceuticals Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Recursion Pharmaceuticals Inc - Class A
Current Price
$2.93
-3.62%GoodMoat Value
$0.63
78.5% overvaluedProfile
Valuation (TTM)
Market Cap$1.55B
P/E-2.76
EV—
P/B1.37
Shares Out527.40M
P/Sales23.27
Revenue$66.41M
EV/EBITDA—
RXRX (RXRX) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for RXRX yet. Check back after the next earnings report.
← Back to RXRX overview